ISRG logo

Intuitive Surgical Stock Price

Symbol: NasdaqGS:ISRGMarket Cap: US$173.2bCategory: Healthcare

ISRG Share Price Performance

US$483.12
45.12 (10.30%)
28.4% undervalued intrinsic discount
US$675.00
Fair Value
US$483.12
45.12 (10.30%)
28.4% undervalued intrinsic discount
US$675.00
Fair Value
Price US$483.12
AnalystHighTarget US$675.00
AnalystConsensusTarget US$583.64
Unike US$325.55

ISRG Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value US$675.00 28.4% undervalued intrinsic discount

Da Vinci 5 Rollout Will Leverage Aging And Digital Trends

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value US$583.64 17.2% undervalued intrinsic discount

Emerging Markets Will Expand Robotic-Assisted Surgery Adoption

0users have liked this narrative
5users have commented on this narrative
148users have followed this narrative
UN
Unike·Updated
Fair Value US$325.55 48.4% overvalued intrinsic discount

Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth

5users have liked this narrative
2users have commented on this narrative
19users have followed this narrative

ISRG Community Fair Values

Recent ISRG News & Updates

No updates

Intuitive Surgical, Inc. Key Details

US$9.1b

Revenue

US$3.1b

Cost of Revenue

US$6.1b

Gross Profit

US$3.5b

Other Expenses

US$2.6b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
7.27
Gross Margin
66.61%
Net Profit Margin
28.51%
Debt/Equity Ratio
0%

Intuitive Surgical, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About ISRG

Founded
1995
Employees
15638
CEO
David Rosa
WebsiteView website
www.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 11.4%
  • 1 Year: 20.5%
  • Year to Date: 5.9%
Over the last 7 days, the market has dropped 2.7%, driven by a decline of 2.4% in the Information Technology sector. As for the longer term, the market has actually risen by 20% in the last year. As for the next few years, earnings are expected to grow by 15% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading